Total Intravenous Anesthesia: TCI Versus MCI

test the following differences between Schinder's Target Controlled Infusion (TCI ) model and manually controlled infusion (MCI) :

* remifentanil and propofol total dose given * incidence of awareness or inadequate anesthesia * number of rescue dose given

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Test the Differences Between Schinder's TCI Model and MCI

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

0532206570

Ferrara, 44121, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients undergoing breast or thyroid surgery

Exclusion criteria

BMI > 35
Surgery shorter than 30 minutes
Patients with history of: alcol or drug abuse, kidney or liver failure, cardiovascular disease

Treatment and study plan

Remifentanil and propofol administration using TCI

Device

Remifentanil and propofol administration using MCI

Device

Primary outcomes

incidence of awareness or inadequate anesthesia

Time frame: every 3 minutes till the end of surgery

Secondary outcomes

remifentanil and propofol total dose given

Time frame: every 30 minutes till the end of surgery

Sponsors and collaborators

Lead sponsor

Università degli Studi di Ferrara

Other

Registry information

Official study title

Total Intravenous Anesthesia: TCI Versus MCI, Unresolved Question

Important dates

Study start: 2012
Primary completion: 2014
Study completion: 2014
First posted: Mar 4, 2014
Registry last updated: Sep 5, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.